Similarly, loss of the phosphatase and tensin homolog (PTEN), a tumor-suppressor protein with a suppressive function against PI3K-mediated AKT activation, is also a potential predictive marker of a poor prognosis in NSCLC patients [27]. This evidence concerns the gene TCHP and non-small cell lung carcinoma.